Instuitional Investor - Arch Venture Corp

13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Maze Therapeutics Inc.	MAZE	4,120,053	$170,693,796	26.19%
2.	Beam Therapeutics Inc.	BEAM	4,540,132	$125,852,459	19.31%
3.	Rapport Therapeutics Inc.	RAPP	3,728,738	$113,129,911	17.36%
4.	Lyell Immunopharma Inc.	LYEL	2,759,072	$84,924,236	13.03%
5.	Vir Biotechnology Inc.	VIR	12,916,663	$77,887,478	11.95%